A Clinical trial to study the effectiveness of Laghumanjishthadi kwath in the management of Vatarakta(Gout)
Phase 1
- Conditions
- Health Condition 1: M109- Gout, unspecified
- Registration Number
- CTRI/2023/06/053846
- Lead Sponsor
- Dr Gunjana Bhardwaj
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients presented with classical symptoms of Vatarakta as mentioned in classical texts (joint pain, swelling, stiffness, reddish blackish discoloration of skin and burning sensation)
2.Raised serum uric acid levels more than 7 mg/dl
3.People of both sexes all socioeconomic conditions and ethnicity
4.Patients willing to participate in the study
Exclusion Criteria
1.Age less than 30 years and more than 70 years
2.Presence of complications of systemic illnesses like nephropathy chronic liver disease
3.Presence of diseases like Carcinoma HIV malignant hypertension uncontrolled diabetes
4.Presence of other joint illnesses like osteoarthritis rheumatoid arthritis SLE
5.Pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To decrease the symptoms of the affected joint as mentioned below <br/ ><br>1. Joint pain <br/ ><br>2. Stiffness <br/ ><br>3. Swelling <br/ ><br>4. Reddish blackish discoloration of skin <br/ ><br>5. Burning sensationTimepoint: 90 days
- Secondary Outcome Measures
Name Time Method To achieve normal serum uric acid & CRP levelsTimepoint: 90 days